The enhanced longevity and liver targetability of Paclitaxel by hybrid liposomes encapsulating Paclitaxel-conjugated gold nanoparticles

International Journal of Pharmaceutics

Volumn 477, Issue 1-2, 2014, Pages 408-415

  Bao, Quan Ying ^a   Zhang, Ning ^a   Geng, Dong Dong ^a   Xue, Jing Wei ^a   Merritt, Mackenzie ^b   Zhang, Can ^a   Ding, Ya ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b UNIVERSITY OF WATERLOO   (Canada)

Author keywords

Anticancer efficacy; Biodistribution; Gold conjugates; Hybrid liposomes; Paclitaxel Pharmacokinetics

Indexed keywords

GOLD NANOPARTICLE; LIPOSOME; MACROGOL 400; PACLITAXEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG TARGETING; ENCAPSULATION; LIVER CANCER; MALE; MOUSE; NONHUMAN; RAT; SUSTAINED DRUG RELEASE;

EID: 84908573643     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2014.10.040     Document Type: Article

References (24)

1. N. Bertrand, J. Wu, X. Xu, N. Kamaly, and O.C. Farokhzad Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology Adv. Drug Delivery Rev. 66 2014 2 25
2. K.V. Chakravarthy, and B.A. Davidson Doxorubicin-conjugated quantum dots to target alveolar macrophages and inflammation Nanomed. Nanotechnol. 7 2011 88 96
3. M.C. Daniel, and D. Astruc Gold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology catalysis and nanotechnology Chem. Rev. 104 2004 293 346
4. A.S.L. Derycke, and P.A.M. Witte Liposomes for photodynamic therapy Adv. Drug Deliv. Rev. 56 2004 17 30
5. Y. Ding, X.H. Xia, and H.S. Zhai Reversible assembly and disassembly of gold nanoparticles directed by a zwitterionic polymer Chem. Eur. J. 13 2007 4197 4302
6. Y. Ding, G. Gu, and X.H. Xia Cysteine-grafted chitosan-mediated gold nanoparticle assembly: from nanochains to microcubes J. Mater. Chem. 19 2009 795 799
7. Y. Ding, Y.Y. Zhou, H. Chen, D.D. Geng, D.Y. Wu, J. Hong, W.B. Shen, T.J. Hang, and C. Zhang The performance of thiol-terminated PEG-paclitaxel-conjugated gold nanoparticles Biomaterials 34 2013 10217 10227
8. Y. Ding, Z. Jiang, K. Saha, C.S. Kim, S.T. Kim, R.F. Landis, and V.M. Rotello Gold nanoparticles for nucleic acid delivery Mol. Ther. 22 2014 1075 1083
9. Y. Ding, J.J. Liang, Z.Y. Liu, D. Wu, L. Dong, X.H. Xia, W.B. Shen, and C. Zhang Development of a liver-targeting gold-PEG-galactose nanoparticle platform and the structure-function study Part. Part. Syst. Charact. 31 2014 347 356
10. O.C. Farokhzad, and R. Langer Impact of nanotechnology on drug delivery ACS Nano 3 2009 16 20
11. R. Gui, A. Wan, X. Liu, and H. Jin Intracellular fluorescent thermometry and photothermal-triggered drug release developed from gold nanoclusters and doxorubicin dual-loaded liposomes Chem. Commun. 50 2014 1546 1548
12. H.R. Jang, H.J. Oh, J.H. Kim, and K.Y. Jung Synthesis of mesoporous spherical silica via spray pyrolysis: Pore size control and evaluation of performance in paclitaxel pre-purification Microporous Mesoporous Mater. 165 2013 219 227
13. K. Kataoka, A. Harada, and Y. Nagasaki Block copolymer micelles for drug delivery: design, characterization and biological significance Adv. Drug Deliv. Rev. 47 2001 113 131
14. D.D. Lasic, and N.S. Templeton Liposomes in gene therapy Adv. Drug Deliv. Rev. 20 1996 221 266
15. J.J. Liang, Y.Y. Zhou, J. Wu, and Y. Ding Gold nanoparticle-based drug delivery platform for antineoplastic chemotherapy Curr. Drug Met. 2014 10.2174/1389200215666140605131427
16. C. Liao, Q. Sun, B. Liang, J. Shen, and X. Shuai Targeting EGFR-overexpressing tumor cells using cetuximab-immunomicelles loaded with doxorubicin and superparamagnetic iron oxide Eur. J. Radiol. 80 2011 699 705
17. Z. Liu, K. Chen, and C. Davis Drug delivery with carbon nanotubes for in vivo cancer treatment Cancer Res. 68 2008 6652 6660
18. D.H. Liu, F.X. Liu, Z.H. Liu, L.L. Wang, and N. Zhang Tumor specific delivery and therapy by double-targeted nanostructured lipid carriers with anti-VEGFR-2 antibody Mol. Pharm. 8 2011 2291 2301
19. J. Oh, H.J. Yoon, and J.H. Park Plasmonic liposomes for synergistic photodynamic and photothermal therapy J. Mater. Chem. B 2 2014 2592 2597
20. A.K. Rengan, M. Jagtap, A. De, R. Banerjee, and R. Srivastava Multifunctional gold coated thermo-sensitive liposomes for multimodal imaging and photothermal therapy of breast cancer cells Nanoscale 6 2014 916 923
21. A. Samad, Y. Sultana, and M. Aqil Liposomal drug delivery systems: an update review Curr. Drug Deliv. 4 2007 297 305
22. R. Sinha, G.J. Kim, S. Nie, and D.M. Shin Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery Mol. Cancer Ther. 5 2006 1909 1917
23. V.P. Torchilin Recent advances with liposomes as pharmaceutical carriers Nat. Rev. Drug Discov. 4 2005 145 160
24. J. Wu, N. Kamly, J. Shi, L. Zhao, Z. Xiao, G. Hollett, R. John, S. Ray, X. Xu, X. Zhang, P.W. Kantoff, and O.C. Farokhzad Development of multinuclear polymeric nanoparticles as robust protein nanocarriers Angew. Chem. Int. Ed. 53 2014 8975 8979